CV-9201

N/A

Report date: 2026/05/12 09:09:29

Base Information

Drug NameCV-9201

Drug Alias NameCV-9201

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermanySwitzerland

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCurevac Ag

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCurevac Ag

Active IndicationsN/A

Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A